VLA 0.00% $1.75 viralytics limited

VLA AGM Presentation, page-11

  1. 3,614 Posts.
    lightbulb Created with Sketch. 685
    Hey skydi,

    As I said on the other thread,

    Agreed their results are increadible, they would be more increadible, if it were out in the community as a viable treatment for cancer, not just stage 4 participants with no hope left for survival but clinical trials..

    The best way to get this out there is with$$$$ and the best way to get cavatak the $$ it needs is a takeover, at these share prices there must be interested parties who can then attract more participants to their trials, as their products ‘keytruda’ or ‘Yervoy’ are known to people who are looking for solutions. With trials full, cavatak should be fast tracked to market..

    The best solution for everyone involved IMHO..
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.